Search

everythinglearnresearchcommunity

for

Search:↓

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

4-aminopyridine speeds up and improves skin wound healing.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Non-drug methods effectively managed agitation in a patient with a heart device, leading to improved mental function.

Feather patterns form through genetic and epigenetic controls, with cells self-organizing into periodic patterns.

Two distinct caspases in human skin help with cell death and skin formation.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Compound 4 is a promising treatment for hair loss with low toxicity.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

ADSC therapy is promising for antiaging skin treatment.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Alzheimer's patients have higher levels of certain chemicals in their hair.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

A new treatment for hair loss shows promise with fewer side effects.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Mobile app ImageMeter calculates scalp area faster and reliably for alopecia treatment.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

4-aminopyridine helps skin wounds heal faster and better.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.